These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8300133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
    Wagner UA, Oehr PF, Reinsberg J, Schmidt SC, Schlebusch HW, Schultes B, Werner A, Prietl G, Krebs D.
    Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
    [Abstract] [Full Text] [Related]

  • 6. Antitumor antibodies for immunotherapy of ovarian carcinomas.
    Wagner U.
    Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
    [No Abstract] [Full Text] [Related]

  • 7. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
    Klug TL, Green PJ, Zurawski VR, Davis HM.
    Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
    [Abstract] [Full Text] [Related]

  • 8. Idiotypic manipulation of the antibody response to a retrovirus-induced tumor.
    Powell TJ, Lamon EW.
    Prog Clin Biol Res; 1989 Jun; 288():289-93. PubMed ID: 2785691
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D, Ross AH, Iliopoulos D, Koprowski H.
    Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.
    Reinsberg J, Nocke W.
    Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
    Glennie MJ, Stevenson GT.
    Adv Exp Med Biol; 1985 May; 186():843-53. PubMed ID: 3876727
    [No Abstract] [Full Text] [Related]

  • 17. [Generation of genetic engineering anti-idiotypic antibody against OC125 monoclonal antibody of ovarian carcinoma].
    Zhang X, Cui H, Qian H.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):646-8. PubMed ID: 9387521
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human antiidiotypic antibodies against OC125 strongly interfere with one-step assays of CA 125 employing OC125 and M11 antibodies.
    Reinsberg J, Gast B.
    Clin Chem; 1994 Jun; 40(6):951-2. PubMed ID: 8087996
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.